These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18602703)

  • 1. Autoantibodies against TRPC3 and ryanodine receptor in myasthenia gravis.
    Takamori M
    J Neuroimmunol; 2008 Aug; 200(1-2):142-4. PubMed ID: 18602703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma.
    Mygland A; Tysnes OB; Aarli JA; Matre R; Gilhus NE
    J Autoimmun; 1993 Aug; 6(4):507-15. PubMed ID: 8216692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
    Mygland A; Tysnes OB; Matre R; Volpe P; Aarli JA; Gilhus NE
    Ann Neurol; 1992 Oct; 32(4):589-91. PubMed ID: 1333745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination and clinical significance of serum anti-ryanodine receptor antibody in patients with myasthenia gravis].
    Cui LY; Li YF; Li YH; Zhang JB
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Apr; 29(2):238-40. PubMed ID: 17536276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibody to dihydropyridine receptor in myasthenia gravis.
    Maruta T; Yoshikawa H; Fukasawa S; Umeshita S; Inaoka Y; Edahiro S; Kado H; Motozaki Y; Iwasa K; Yamada M
    J Neuroimmunol; 2009 Mar; 208(1-2):125-9. PubMed ID: 19187971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ryanodine receptor antibodies in myasthenia gravis: epitope mapping and effect on calcium release in vitro.
    Skeie GO; Mygland A; Treves S; Gilhus NE; Aarli JA; Zorzato F
    Muscle Nerve; 2003 Jan; 27(1):81-9. PubMed ID: 12508299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-ryanodine receptor antibodies and FK506 in myasthenia gravis.
    Takamori M; Motomura M; Kawaguchi N; Nemoto Y; Hattori T; Yoshikawa H; Otsuka K
    Neurology; 2004 May; 62(10):1894-6. PubMed ID: 15159506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent advance in research for myasthenia gravis, in relation to various antibodies affecting synaptic structure and function].
    Takamori M
    Rinsho Shinkeigaku; 2009 Nov; 49(11):789-93. PubMed ID: 20030211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striational antibodies in myasthenia gravis: reactivity and possible clinical significance.
    Romi F; Skeie GO; Gilhus NE; Aarli JA
    Arch Neurol; 2005 Mar; 62(3):442-6. PubMed ID: 15767509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis.
    Mygland A; Aarli JA; Matre R; Gilhus NE
    J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):843-6. PubMed ID: 8021674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmunity against the ryanodine receptor in myasthenia gravis.
    Skeie GO; Lunde PK; Sejersted OM; Mygland A; Aarli JA; Gilhus NE
    Acta Physiol Scand; 2001 Mar; 171(3):379-84. PubMed ID: 11412151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myasthenia gravis-associated ryanodine receptor antibodies inhibit binding of ryanodine to sarcoplasmic reticulum.
    Skeie GO; Lunde PK; Sejersted OM; Mygland A; Aarli JA; Gilhus NE
    Ann N Y Acad Sci; 1998 May; 841():530-3. PubMed ID: 9668288
    [No Abstract]   [Full Text] [Related]  

  • 13. Myasthenia gravis sera containing antiryanodine receptor antibodies inhibit binding of [3H]-ryanodine to sarcoplasmic reticulum.
    Skeie GO; Lunde PK; Sejersted OM; Mygland A; Aarli JA; Gilhus NE
    Muscle Nerve; 1998 Mar; 21(3):329-35. PubMed ID: 9486861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-ryanodine receptor antibody and the thymus gland in myasthenia gravis].
    Iwasa K; Asaka T; Takamori M
    Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):655-63. PubMed ID: 9627474
    [No Abstract]   [Full Text] [Related]  

  • 15. Is excitation-contraction coupling impaired in myasthenia gravis?
    Nakata M; Kuwabara S; Kawaguchi N; Takahashi H; Misawa S; Kanai K; Tamura N; Sawai S; Motomura M; Shiraishi H; Takamori M; Maruta T; Yoshikawa H; Hattori T
    Clin Neurophysiol; 2007 May; 118(5):1144-8. PubMed ID: 17307394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thymectomy and muscle antibodies in myasthenia gravis].
    Romi F; Gilhus NE; Aarli JA
    Tidsskr Nor Laegeforen; 2004 Mar; 124(5):629-31. PubMed ID: 15004605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification of myasthenia gravis based on autoantibody status.
    Suzuki S; Utsugisawa K; Nagane Y; Satoh T; Terayama Y; Suzuki N; Kuwana M
    Arch Neurol; 2007 Aug; 64(8):1121-4. PubMed ID: 17698702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of late-onset, thymoma-associated myasthenia gravis with ryanodine receptor and titin antibodies and concomitant granulomatous myositis.
    Stefanou MI; Komorowski L; Kade S; Bornemann A; Ziemann U; Synofzik M
    BMC Neurol; 2016 Sep; 16(1):172. PubMed ID: 27623618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmunity to ryanodine receptor and titin in myasthenia gravis is associated with GM allotypes.
    Skeie GO; Pandey JP; Aarli JA; Gilhus NE
    Autoimmunity; 1997; 26(2):111-6. PubMed ID: 9546812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-cardiac ryanodine receptor antibodies in thymoma-associated myasthenia gravis.
    Mygland A; Tysnes OB; Matre R; Aarli JA; Gilhus NE
    Autoimmunity; 1994; 17(4):327-31. PubMed ID: 7948615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.